Literature DB >> 10886554

An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis.

Y Ikezumi1, H Kawachi, S Toyabe, M Uchiyama, F Shimizu.   

Abstract

BACKGROUND: Increased numbers of lymphocytes have been identified in biopsy specimens of human mesangial proliferative glomerulonephritis (GN). However, the causal relationship between infiltrating T lymphocytes and mesangial changes in mesangial proliferative GN has not been previously evaluated. In this study, we elucidated the role of lymphocytes in the development of mesangial proliferative GN.
METHOD: Immunohistological and flow cytometric analyses as well as a reverse transcription-polymerase chain reaction (RT-PCR) studies were performed in monoclonal antibody (mAb) 1-22-3-induced Thy 1.1 GN. To elucidate the role of these lymphocytes, depletion studies were carried out using anti-CD8 mAb (OX-8), which depletes both CD8+ T lymphocytes and natural killer (NK) cells and anti-CD5 mAb (OX-19), which depletes both CD4+ and CD8+ T lymphocytes.
RESULTS: Immunofluorescence (IF) studies revealed that NK cells and CD4+ T lymphocytes were recruited into glomeruli. Glomerular mRNA expression for interferon-gamma, interleukin-2 (IL-2), IL-10, and perforin increased after induction of GN. Increased expressions of several chemokines, which have the potential to attract lymphocytes, were also detected. Anti-CD8 mAb treatment completely prevented the recruitment of NK cells; however, it had no protective effect on proteinuria and mesangial injury. By contrast, anti-CD5 mAb treatment suppressed the recruitment of CD4+ T lymphocytes into glomeruli and reduced proteinuria (60.4 +/- 25.7 vs. 120.0 +/- 32.3 mg/day, P < 0.05) and mesangial changes evaluated by total number of cells in glomeruli (63.2 +/- 6.0 vs. 81.4 +/- 5.9, P < 0.01) and alpha-smooth muscle actin staining score (1.4 +/- 0.2 vs. 2.2 +/- 0. 4, cf2eth P < 0.01) on day 14 after induction of GN. mRNA expression for IL-2 was significantly reduced by OX-19 treatment.
CONCLUSION: T lymphocytes participate in the development of mesangial proliferative GN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886554     DOI: 10.1046/j.1523-1755.2000.00145.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

2.  Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis.

Authors:  Jukka M Rintala; Johanna Savikko; Sini E Rintala; Niina Palin; Petri K Koskinen
Journal:  J Nephrol       Date:  2015-09-30       Impact factor: 3.902

3.  Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6.

Authors:  Takashi Maruyama; Noboru Fukuda; Taro Matsumoto; Koichiro Kano; Morito Endo; Minako Kazama; Tomohiko Kazama; Jin Ikeda; Hiroyuki Matsuda; Takahiro Ueno; Masanori Abe; Kazuyoshi Okada; Masayoshi Soma; Koichi Matsumoto; Hiroshi Kawachi
Journal:  Stem Cell Res Ther       Date:  2015-04-16       Impact factor: 6.832

4.  Suppressor of Cytokine Signaling-1/STAT1 Regulates Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models.

Authors:  Jiuxu Bai; Lingling Wu; Xiaoniao Chen; Liqiang Wang; Qinggang Li; Yingjie Zhang; Jie Wu; Guangyan Cai; Xiangmei Chen
Journal:  Front Immunol       Date:  2018-08-30       Impact factor: 7.561

Review 5.  Natural Killer Cells in Kidney Health and Disease.

Authors:  Jan-Eric Turner; Constantin Rickassel; Helen Healy; Andrew J Kassianos
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

6.  Mesangial Cells Exhibit Features of Antigen-Presenting Cells and Activate CD4+ T Cell Responses.

Authors:  Hongyu Yu; Shaoyuan Cui; Yan Mei; Qinggang Li; Lingling Wu; Shuwei Duan; Guangyan Cai; Hanyu Zhu; Bo Fu; Li Zhang; Zhe Feng; Xiangmei Chen
Journal:  J Immunol Res       Date:  2019-06-17       Impact factor: 4.818

Review 7.  Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.

Authors:  María Velasco-de Andrés; Sergi Casadó-Llombart; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Fernando Aranda
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.